amiodarone has been researched along with Lipoma in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Lipoma: A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.
Excerpt | Relevance | Reference |
---|---|---|
"Cardiac lipomas are rare benign heart tumors." | 1.56 | Ventricular tachycardia: beginning and ending fate of a benign invasive cardiac lipoma. ( Ahmed, MM; Aladmawi, M; Alamro, B; ALsanei, A; AlSomali, A; Echahidi, NM; Fawzy, N; Kharabsheha, S; Vriz, O, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Vriz, O | 1 |
Ahmed, MM | 1 |
Kharabsheha, S | 1 |
Aladmawi, M | 1 |
Alamro, B | 1 |
AlSomali, A | 1 |
Fawzy, N | 1 |
ALsanei, A | 1 |
Echahidi, NM | 1 |
Fukushima, KK | 1 |
Mitani, T | 1 |
Hashimoto, K | 1 |
Hosogi, S | 1 |
Emori, T | 1 |
Morita, H | 1 |
Fujimoto, Y | 1 |
Nakamura, K | 1 |
Yamanari, H | 1 |
Ohe, T | 1 |
2 other studies available for amiodarone and Lipoma
Article | Year |
---|---|
Ventricular tachycardia: beginning and ending fate of a benign invasive cardiac lipoma.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantab | 2020 |
Ventricular tachycardia in a patient with cardiac lipoma.
Topics: Administration, Oral; Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Follow-Up Stud | 1999 |